Anticoccidial drugs market is being driven by factors such as the rising incidence of coccidiosis in food-producing animals and companion animals, coupled with the rising awareness regarding animal health across the globe.

Also, advancements in veterinary healthcare are one of the major factors fueling the growth of the market studied across the world. For instance, in April 2019, Creative Diagnostics announced the launch of a series of innovative anticoccidial drug analysis products and services for its global clients.

However, the use of alternative treatments, such as vaccines and herbal remedies, to treat Coccidiosis is likely to hamper the growth of anticoccidial drugs market across the world.

Key Market Trends

The Ionophore Anticoccidial segment dominates the Anticoccidial Drugs Market

  • A major breakthrough in the prevention of coccidiosis through feed medication occurred in 1972, with the launch of the first polyether ionophore anticoccidial, monensin. This type of anticoccidial agent has been commonly referred to as ionophores, a term derived from their general chemical structure. Ionophores are the fermentation products of Streptomyces and other fungi species.
  • Furthermore, these drugs are widely used for the prevention of coccidiosis, due to its broad-spectrum activity against the majority of pathogenic species of coccidian and lack of development of drug resistance. Each has a different mode of action and no significant resistance has been developed. These drugs are commonly added to the starter and grower feeds, but not to the finisher or withdrawal feeds.
  • Furthermore, when the same ionophore anticoccidial is added to the starter and grower feeds, it is known as a straight program. In 2017, the US Food and Drug Administration reported that 82% of all domestic sales and distribution of non-medically important antimicrobials were from ionophores, amounting to 4,394,850?kilo gram.
  • As a result of the aforementioned factors, the ionophore anticoccidial segment is expected to experience healthy growth during the forecast period.



North America is the fastest growing region in the Anticoccidial Drugs Market

North America is the major market for anticoccidial drugs, globally. Currently, the North American anticoccidial drugs market is witnessing significant growth. This can be attributed to the availability of multiple anticoccidial drugs, both chemicals and polyether ionophores, as well as the prophylactic usage of anticoccidials in animal feed. Furthermore, factors, such as rising awareness regarding the prevention of coccidiosis, safe animal food supply, and high investment in R&D, mainly for developing novel products, are likely to propel the North American anticoccidial drugs market’s growth during the forecast period.

Competitive Landscape

The anticoccidial market is competitive. Major market players are primarily focusing on continuous product development, while adopting growth strategies, such as mergers, acquisitions, and partnerships with other market players. Major players include Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health, Merck, Merial, Virbac, and Zoetis Animal Healthcare, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support